Squarepoint
STOK icon

Squarepoint’s Stoke Therapeutics STOK Stock Holding History

Squarepoint’s Portfolio STOK Stock Details STOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-23,458
Closed -$266K – 4977
2025
Q2 		$266K Buy
+23,458
New +$223K ﹤0.01% 3776
2025
Q1 		– Sell
-120,242
Closed -$1.33M – 5381
2024
Q4 		$1.33M Buy
120,242
+7,575
+7% +$93.1K ﹤0.01% 2801
2024
Q3 		$1.38M Buy
112,667
+97,625
+649% +$1.38M ﹤0.01% 2352
2024
Q2 		$203K Sell
15,042
-36,055
-71% -$487K ﹤0.01% 3654
2024
Q1 		$690K Buy
51,097
+32,001
+168% +$194K ﹤0.01% 2840
2023
Q4 		$100K Buy
19,096
+3,886
+26% +$16.6K ﹤0.01% 3754
2023
Q3 		$59.9K Buy
+15,210
New +$100K ﹤0.01% 3617
2023
Q2 		– Sell
-17,851
Closed -$149K – 3994
2023
Q1 		$149K Buy
+17,851
New +$161K ﹤0.01% 2894
2021
Q3 		– Sell
-6,495
Closed -$219K – 3407
2021
Q2 		$219K Sell
6,495
-4,217
-39% -$149K ﹤0.01% 2757
2021
Q1 		$416K Buy
+10,712
New +$610K ﹤0.01% 2157
2020
Q4 		– Sell
-10,837
Closed -$363K – 3247
2020
Q3 		$363K Buy
+10,837
New +$309K ﹤0.01% 1661
2020
Q1 		– Sell
-20,286
Closed -$574K – 2483
2019
Q4 		$574K Sell
20,286
-1,413
-7% -$35.5K ﹤0.01% 1688
2019
Q3 		$466K Buy
+21,699
New +$605K ﹤0.01% 1659

Other funds holding STOK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ST
Skorpios Trust Limassol, Cyprus $53.2M AUM 90.96% 1-Year Est. Return

Squarepoint's STOK Position: Q3 2025 in Review

Squarepoint sold out of Stoke Therapeutics (STOK) in Q3 2025, closing a stake of 23,458 shares — an estimated $266K sold.

Squarepoint first reported a position in STOK in Q3 2019 and held it in 13 quarters. The position peaked at $1.38M in Q3 2024. 151 funds tracked by Wall St. Rank hold STOK as of Q3 2025.

  • Squarepoint reported no remaining Stoke Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Squarepoint sold 23,458 Stoke Therapeutics shares in Q3 2025, an estimated $266K.
  • Squarepoint first reported a position in Stoke Therapeutics in Q3 2019 and held it in 13 quarters.
  • Squarepoint's Stoke Therapeutics position peaked at $1.38M in Q3 2024.
  • 151 funds tracked by Wall St. Rank held Stoke Therapeutics as of Q3 2025.

Based on Squarepoint's 13F filing for Q3 2025, filed 14 Nov 2025.